IMUX
IMMUNIC, INC.
$12.06
-5.56%
$164.3M
No data for this timeframe.
Vol
Market Cap$164.3M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (94%)
Inst. Holders6 funds
Inst. Value$3.9M
Inst. Activity1 buys / 2 sells
Reddit Sentiment68° Warm
SEC Reports7
Recent Activity
May 22, 2026
Insider
Lundgren Erik sold 1,000,000 shares
Chief Executive Officer @ $0.00 ($0.00)
May 19, 2026
SEC
Michael W. Bonney filed an initial statement of beneficial ownership (Form 3) with the SEC, reporting no securities bene
3 — Impact 2/10
May 19, 2026
SEC
Immunic appointed Michael W. Bonney as Chair of the Board, effective May 16, 2026. Bonney brings extensive biopharmaceut
8-K — Impact 3/10
May 13, 2026
earnings_calendar
IMUX Q1 2026 Earnings Before Market Open — 2026-05-13
Apr 30, 2026
SEC
Immunic filed Amendment No. 1 to its S-3 shelf registration to register the resale of up to 45,815,180 shares of common
S-3/A — Impact 8/10
Apr 24, 2026
Insider
Panzara Michael A. sold 300,000 shares
Chief Medical Officer @ $0.00 ($0.00)
Inst.
MORGAN STANLEY — TRIM
2,091,011 shares ($1.1M)
Inst.
TWO SIGMA INVESTMENTS, LP — ADD
76,186 shares ($40.7K)
Price Targets
$44.67
+264.3% upside
Strong Buy
Current $12.26
Low $19.00
Median $40.00
High $85.00
9 analysts
$19.00
$85.00
Analyst Ratings
7Strong Buy
8Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 22, 2026 | B. Riley Securities | MAINTAIN | Buy → Buy |
| Apr 30, 2026 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
| Apr 17, 2026 | Stifel | INITIATE | Buy |
| Apr 15, 2026 | D. Boral Capital | DOWNGRADE | Buy → Hold |
| Mar 24, 2026 | Guggenheim | INITIATE | Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-1.18 ▼ -13.3% | $-2.41 — $-0.63 | 41% YoY | 9 |
| Next Q | $-1.19 ▼ -11.0% | $-2.21 — $-0.68 | 8% YoY | 9 |
| Current FY | $-4.38 ▼ -10.2% | $-7.02 — $-2.66 | 29% YoY | 9 |
| Next FY | $-3.55 ▼ -6.3% | $-9.05 — $-0.60 | 19% YoY | 8 |
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $2.7M | — |
| MORGAN STANLEY | $1.1M | TRIM |
| TWO SIGMA INVESTMENTS, LP | $40.7K | ADD |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $13.3K | NEW |
| WELLS FARGO & COMPANY/MN | $480.00 | DOUBLED |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 22, 2026 | Lundgren Erik | A | $0.00 |
| Apr 24, 2026 | Panzara Michael | A | $0.00 |
Reddit Sentiment
68°
Warm
Bearish
Neutral
Bullish
6 institutional holders with $3.9M total value (7,213,612 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, TWO. Net selling activity: 2 institutions trimmed/exited vs 1 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 5,020,337 | $2.7M | 69.6% | — |
| 2 | MORGAN STANLEY | 2,091,011 | $1.1M | 29.0% | TRIM -32.6% |
| 3 | TWO SIGMA INVESTMENTS, LP | 76,186 | $40.7K | 1.1% | ADD +29.8% |
| 4 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 25,000 | $13.3K | 0.3% | NEW |
| 5 | WELLS FARGO & COMPANY/MN | 900 | $480.00 | 0.0% | DOUBLED +431.5% |
| 6 | BANK OF AMERICA CORP /DE/ | 178 | $95.00 | 0.0% | NEAR_EXIT -83.7% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | TRIM | 3,103,122 | 2,091,011 | -32.6% | $1.1M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | ADD | 58,681 | 76,186 | +29.8% | $40.7K | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 391,653 | 0 | -100.0% | $0.00 | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 132,154 | 391,653 | +196.4% | $345.3K | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 58,681 | — | $51.7K | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 376,104 | 38,687 | -89.7% | $34.1K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 1,040 | 170 | -83.7% | $150.00 | 2025-Q3 |
| MORGAN STANLEY | DOUBLED | 567,612 | 3,628,528 | +539.3% | $2.5M | 2025-Q2 |
| UBS Group AG | DOUBLED | 149,050 | 376,104 | +152.3% | $262.5K | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | NEAR_EXIT | 669,464 | 132,154 | -80.3% | $92.2K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 197 | 1,047 | +431.5% | $730.00 | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 19,566 | 1,040 | -94.7% | $725.00 | 2025-Q2 |
| MORGAN STANLEY | TRIM | 1,104,756 | 567,612 | -48.6% | $618.7K | 2025-Q1 |
| UBS Group AG | DOUBLED | 27,197 | 149,050 | +448.0% | $162.5K | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 140,100 | 54,200 | -61.3% | $59.1K | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 157,204 | 0 | -100.0% | $0.00 | 2025-Q1 |
| MORGAN STANLEY | DOUBLED | 390,710 | 1,104,756 | +182.8% | $1.1M | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 389,081 | 566,623 | +45.6% | $566.6K | 2024-Q4 |
| CITADEL ADVISORS LLC | TRIM | 329,357 | 140,100 | -57.5% | $140.1K | 2024-Q4 |
| UBS Group AG | DOUBLED | 2,439 | 27,197 | +1015.1% | $27.2K | 2024-Q4 |
| MORGAN STANLEY | DOUBLED | 25,404 | 390,710 | +1438.0% | $644.7K | 2024-Q3 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 25,000 | — | $41.3K | 2024-Q3 |
2 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 22, 2026 | Lundgren Erik | Chief Executive Officer | A | 1,000,000 | $0.00 | $0.00 |
| Apr 24, 2026 | Panzara Michael A. | Chief Medical Officer | A | 300,000 | $0.00 | $0.00 |
7 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 5 neutral. Avg impact: 4.6/10.
NEUTRAL
3
2/10
Michael W. Bonney filed an initial statement of beneficial ownership (Form 3) with the SEC, reportin
May 19, 2026
NEUTRAL
8-K
3/10
Immunic appointed Michael W. Bonney as Chair of the Board, effective May 16, 2026. Bonney brings ext
May 19, 2026
BEARISH
S-3/A
8/10
Immunic filed Amendment No. 1 to its S-3 shelf registration to register the resale of up to 45,815,1
Apr 30, 2026
NEUTRAL
8-K
4/10
Immunic, Inc. (IMUX) announced a 1-for-10 reverse stock split effective April 27, 2026, reducing its
Apr 23, 2026
NEUTRAL
8-K
4/10
Immunic, Inc. (IMUX) announced that shareholders approved a proposal to authorize the board to imple
Apr 14, 2026
NEUTRAL
8-K
3/10
Immunic, Inc. announced a retention bonus agreement with CEO Daniel Vitt, totaling $670,000, conting
Apr 10, 2026
BULLISH
8-K
8/10
Immunic, Inc. reported its 2025 financial results, showing a reduced net loss of $97.2 million compa
Feb 26, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (94% buy). Based on 16 analysts: 7 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$44.67 mean target
+264.3% upside
Strong Buy (1.00)
$19.00 Low
$85.00 High
| Metric | Value |
|---|---|
| Current Price | $12.26 |
| Target Low | $19.00 |
| Target Mean | $44.67 |
| Target Median | $40.00 |
| Target High | $85.00 |
| # Analysts | 9 |
| Recommendation | Strong Buy (1.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-1.18 | $-2.41 | $-0.63 | 41.2% | -13.3% | 2↑ 4↓ | $0.0B | 0.0% | 9 |
| Next Q 2026-09-30 |
$-1.19 | $-2.21 | $-0.68 | 8.2% | -11.0% | 2↑ 4↓ | $0.0B | 0.0% | 9 |
| Current FY 2026-12-31 |
$-4.38 | $-7.02 | $-2.66 | 29.3% | -10.2% | 2↑ 6↓ | $0.0B | 0.0% | 9 |
| Next FY 2027-12-31 |
$-3.55 | $-9.05 | $-0.60 | 19.1% | -6.3% | 3↑ 4↓ | $0.0B | 0.0% | 8 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-1.176 | |
| 7d ago | $-1.259 | +0.083 |
| 30d ago | $-1.038 | -0.138 |
| 60d ago | $-1.200 | +0.024 |
| 90d ago | $-1.038 | -0.138 |
5 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 2 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 22, 2026 | B. Riley Securities | MAINTAIN | Buy | Buy |
| Apr 30, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Apr 17, 2026 | Stifel | INITIATE | — | Buy |
| Apr 15, 2026 | D. Boral Capital | DOWNGRADE | Buy | Hold |
| Mar 24, 2026 | Guggenheim | INITIATE | — | Buy |
| Mar 2, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Feb 13, 2026 | D. Boral Capital | MAINTAIN | Buy | Buy |
| Feb 9, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jan 7, 2026 | D. Boral Capital | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 7 | 8 | 1 | 0 | 0 | 94% | |
| May 1, 2026 | 6 | 7 | 1 | 0 | 0 | 93% | |
| Apr 1, 2026 | 6 | 8 | 1 | 0 | 0 | 93% | |
| Mar 1, 2026 | 5 | 9 | 1 | 0 | 0 | 93% | |
| Feb 1, 2026 | 5 | 9 | 1 | 0 | 0 | 93% | |
| Jan 1, 2026 | 5 | 9 | 1 | 0 | 0 | 93% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
68°
Warm
Bearish
Neutral
Bullish
7 mentions
4 bullish
0 bearish
6 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 27, 2026 | 2 | 58° Warm | 1 | 0 | 2 |
| May 27, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Mar 3, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 2, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Feb 25, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Feb 13, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
IMUX TLDR Anyone watching it?
▲ 1
💬 0
⚡ 0.5
IMUX TLDR? What’s your opinion?
▲ 1
💬 0
⚡ 0.5
Immunic (IMUX)
▲ 1
💬 1
⚡ 0.5
Anyone else stumble upon IMUX?
▲ 1
💬 0
⚡ 0.5
IMUX to the 🌕 ?
▲ 1
💬 3
⚡ 0.0
Time to buy $IMUX!
▲ 2
💬 4
⚡ 0.0
May 13, 2026
earnings_calendar
IMUX Q1 2026 Earnings Before Market Open — 2026-05-13
Apr 24, 2026
short_volume
Short Volume: IMUX — 62.3% short (1.3M / 2.0M)
Short: 1,259,680 | Exempt: 200 | TRF Vol: 2,023,275 | Short Ratio: 62.3% | Off-exchange volume (dark pool + OTC)
Apr 20, 2026
short_volume
Short Volume: IMUX — 68.3% short (2.9M / 4.2M)
Short: 2,855,230 | Exempt: 27,992 | TRF Vol: 4,180,579 | Short Ratio: 68.3% | Off-exchange volume (dark pool + OTC)
Apr 16, 2026
short_volume
Short Volume: IMUX — 62.6% short (3.0M / 4.8M)
Short: 3,006,949 | Exempt: 304,214 | TRF Vol: 4,805,744 | Short Ratio: 62.6% | Off-exchange volume (dark pool + OTC)
Apr 14, 2026
short_volume
Short Volume: IMUX — 60.9% short (0.6M / 1.0M)
Short: 600,111 | Exempt: 2,000 | TRF Vol: 985,569 | Short Ratio: 60.9% | Off-exchange volume (dark pool + OTC)
Apr 10, 2026
short_volume
Short Volume: IMUX — 68.1% short (0.9M / 1.3M)
Short: 892,896 | Exempt: 40,793 | TRF Vol: 1,310,702 | Short Ratio: 68.1% | Off-exchange volume (dark pool + OTC)
Apr 8, 2026
short_volume
Short Volume: IMUX — 61.2% short (0.4M / 0.6M)
Short: 353,725 | Exempt: 200 | TRF Vol: 577,841 | Short Ratio: 61.2% | Off-exchange volume (dark pool + OTC)